Skip to content
http://lifestyle.matomyseo.com/
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
BriaCell Therapeutics Corp.
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
October 23, 2026
BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting
October 6, 2026
Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell’s Phase 3 Metastatic Breast Cancer Study
September 14, 2026
BriaCell Phase 3 Metastatic Breast Cancer Trial Expands to MSK
September 8, 2026
BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™
August 24, 2026
BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer
July 16, 2026
BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™
July 15, 2026
BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™
July 7, 2026
BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™
June 25, 2026
BriaCell Therapeutics Announces Closing of Offering
June 2, 2026
1
2
3
Next Page
→